Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Anne-Laure
Anne-Laure Beaudonnet, Salon De Provence FR
| Patent application number | Description | Published |
|---|---|---|
| 20110053463 | SHOT BLASTING PARTICLES - Shot blasting particles are constituted by a ceramic material having an apparent relative density of more than 4.0 and less than 5.0 and comprising more than 5% of silica, as a percentage by weight based on the oxides. | 03-03-2011 |
Anne-Laure Becquet, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20110236772 | MANUFACTURING METHODS FOR AIR ELECTRODE - A method of forming an air electrode of a metal-air battery includes forming a plurality of layers of the air electrode. The plurality of layers include an active layer and a gas diffusion layer. Forming the active layer includes forming a plurality of blank portions in a sublayer of the active layer for venting gases to the gas diffusion layer. | 09-29-2011 |
| 20110236798 | MANUFACTURING METHODS FOR AIR ELECTRODE - A method of forming an air electrode of a metal-air battery includes forming at least a portion of the air electrode using a process selected from the group consisting of screen printing, spray printing, spin coating, and dip coating. | 09-29-2011 |
| 20110236799 | MANUFACTURING METHODS FOR AIR ELECTRODE - Methods of forming an air electrode of a metal-air battery are provided. One method includes forming a plurality of layers of the air electrode. The plurality of layers include an active layer and a gas diffusion layer. Forming at least one of the active layer or the gas diffusion layer includes forming a first sublayer having a first concentration of a first material and forming a second sublayer having at least one of a second concentration of the first material that differs from the first concentration or a second material that differs from the first material. In another embodiment, a method includes forming a layer of an air electrode such that a gradient of a material is formed in at least a portion of the layer by varying a concentration of the material deposited between a first portion of the layer and a second portion of the layer. | 09-29-2011 |
Anne-Laure Blayo, Credin FR
| Patent application number | Description | Published |
|---|---|---|
| 20120083494 | NOVEL TRIAZOLE DERIVATIVES WITH IMPROVED RECEPTOR ACTIVITY AND BIOAVAILABILITY PROPERTIES AS GHRELIN ANTAGONISTS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS - The present invention provides novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin analogue ligands of growth hormone secretagogue receptors according to formula (I) that are useful in the treatment or prophylaxis of physiological and/or pathophysiological conditions in mammals, preferably humans, that are mediated by GHS receptors. The present invention further provides GHS receptor antagonists and agonists that can be used for modulation of these receptors and are useful for treating above conditions, in particular alcohol disorder, drug abuse, growth retardation, cachexia, short-, medium-, and/or long term regulation of energy balance, short-, medium-, and/or long term regulation (stimulation and/or inhibition) of food intake, intake of rewarding food, adipogenesis, adiposity and/or obesity, body weight gain and/or reduction, diabetes, diabetes type I, diabetes type II, tumor cell proliferation, inflammation, inflammatory effects, gastric postoperative ileus, postoperative ileus and/or gastrectomy (ghrelin replacement therapy). | 04-05-2012 |
Anne-Laure Bolcato Bellemin, Strasbourg FR
| Patent application number | Description | Published |
|---|---|---|
| 20100048672 | COMPOSITIONS FOR TRANSFECTION OF OLIGONUCLEOTIDES ACTIVE FOR GENE SILENCING AND THEIR BIOLOGICAL AND THERAPEUTICAL APPLICATIONS - The invention relates to compositions of transfection comprising an oligonucleotide and an amphiphilic cationic molecule of formula (I) wherein, —X is N—R | 02-25-2010 |
Anne-Laure Calendron, Hohenems AT
| Patent application number | Description | Published |
|---|---|---|
| 20090034564 | Method and apparatus for detecting and avoiding multiple-pulse states in ultra-short-pulse laser - In a detection method for undesired double- or multiple-pulse states in an ultra-short-pulse laser system operated in the soliton regime and intended for generating femtosecond or picosecond pulses, comprising an amplifying laser medium for producing a laser emission, a laser resonator having at least one resonator mirror and a pump source, a first signal μ proportional to the pulse power P(t) or pulse energy averaged over the resonator cycle is measured for the laser emission. A second signal ν proportional to the square of the pulse power P(t), averaged over the resonator cycle, is measured for the laser emission, and the occurrence of a double- or multiple-pulse state is detected on the basis of a comparison of the measured signals μ and ν. | 02-05-2009 |
Anne-Laure Flamar, Dallas, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100135994 | HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS - The present invention includes compositions and methods for making and using a vaccine that includes a DC-specific antibody or fragment thereof to which an engineered Gag antigen is attached to form an antibody-antigen complex, wherein the Gag antigen is less susceptible to proteolytic degradation by eliminating one or more proteolytic sites or a DC-specific antibody or fragment thereof to which an engineered Nef antigen is attached to form an antibody-antigen complex, wherein the Nef antigen comprises one or more codon usage optimization that increase antibody-antigen complex secretion, or both, wherein the vaccine is able to elicit an HIV-specific T cell immune response to Gag p17, Gag p24, Nef and/or Cyclin D1. | 06-03-2010 |
| 20100291082 | ANTIGEN PRESENTING CELL TARGETED ANTI-VIRAL VACCINES - The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies. | 11-18-2010 |
| 20100297114 | ANTIGEN PRESENTING CELL TARGETED VACCINES - The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies. | 11-25-2010 |
| 20100322929 | ANTIGEN PRESENTING CELL TARGETED CANCER VACCINES - The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies. | 12-23-2010 |
| 20100330115 | Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody - The present invention includes compositions and methods for designing, making and using modular recombinant antibodies or fragments thereof with one half of a cohesin-dockerin pair that permits the rapid assembly of multivariant antigen conjugates. | 12-30-2010 |
| 20120004643 | Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells - The present invention includes compositions and methods for increasing the effectiveness of antigen presentation using a DCIR-specific antibody or fragment thereof to which an antigen is attached that forms an antibody-antigen complex, wherein the antigen is processed and presented by a dendritic cell that has been contacted with the antibody-antigen complex. | 01-05-2012 |
| 20120039916 | NOVEL VACCINE ADJUVANTS BASED ON TARGETING ADJUVANTS TO ANTIBODIES DIRECTLY TO ANTIGEN-PRESENTING CELLS - Compositions and methods for enhancing an immune response with an adjuvant composition comprising: an anti-dendritic cell (DC)-specific antibody or fragment thereof conjugated to at least a portion of a TLR agonist; and a pharmaceutically acceptable carrier are disclosed herein. The conjugate and agonist are each comprised in an amount such that, in combination with the other, are effective to produce the immune response in a human or animal subject in need of immunostimulation. | 02-16-2012 |
Anne-Laure Gibouin, F-Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20090255271 | STRUCTURAL NACELLE - The present invention relates, on the one hand, to a nacelle ( | 10-15-2009 |
Anne-Laure Joudrier, Vert-Saint-Denis FR
| Patent application number | Description | Published |
|---|---|---|
| 20090133811 | PROCESS FOR TRANSFERRING FILMS - A process of transferring a layer of a first material from a first substrate, having defects in a zone close to the surface, onto a host substrate made of a second material includes a step of thinning the first substrate in order to form a first thinned substrate, an ion or atom implantation in the first substrate in order to form an implantation plane therein, delimiting the layer to be transferred, and a transfer of the layer onto the host substrate by fracturing the substrate along the implantation plane. | 05-28-2009 |
Anne-Laure Lafly, Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20100170986 | AIRCRAFT STRUCTURAL ELEMENT LOCATED AT THE INTERFACE BETWEEN A WING AND THE FUSELAGE - An aircraft structural element situated at an interface between a wing and the fuselage, and including a web and profiled elements flanking the web. At least one the profiled element includes a flat part positioned without overlap in the continuation of a flat part of the web and connected thereto by a welded butt joint using friction stir welding. | 07-08-2010 |
| 20110203343 | Method To Achieve A Stiffened Curved Metallic Structure And Structure Obtained Accordingly - The invention relates to a process for making a reinforced curved metallic structure, made from a heavy-gauge or plate-gauge sheet of an aluminium alloy containing scandium. | 08-25-2011 |
Anne-Laure Lesort, Gien FR
| Patent application number | Description | Published |
|---|---|---|
| 20090314626 | METHOD FOR TREATING EFFLUENTS CONTAINING FLUOROCOMPOUNDS LIKE PFC AND HFC - The invention relates to a method for destroying effluents issuing from a reactor, the said effluents being transported through at least one pump towards plasma means capable of destroying at least certain bonds in the molecules of the PFC or HFC type between the fluorine and the other elements of these molecules of the PFC or HFC type, in order to generate first species which are then converted to second gaseous, liquid or solid species before interaction of these second species with dry or wet purifying means. According to the invention, at least one reducing agent is injected upstream and/or downstream of the plasma, but upstream of the purifying means, in order to react with the first species created. | 12-24-2009 |
Anne-Laure Molinier, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20120122176 | CELLULASE CEL5H RELATED REAGENTS AND THEIR USE IN MICROORGANISMS - The invention relates to applications of the cellulase Cel5H of | 05-17-2012 |
Anne-Laure Turcot-Dubois, Les Lucs Sur Boulogne FR
| Patent application number | Description | Published |
|---|---|---|
| 20110028411 | ALPHA-GALACTOCERAMIDE ANALOGS, THEIR METHODS OF MANUFACTURE, INTERMEDIATE COMPOUNDS USEFUL IN THESE METHODS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The invention relates to α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize α-galactoceramide analogs by a mere metathesis reaction. The α-galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties. | 02-03-2011 |
Anne-Laure Vayssade, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110301620 | DEVICE FOR SUTURING TWO HOLLOW BIOLOGICAL TISSUES - The device comprises a first part able to be provided on the free side of one of two hollow biological tissues bearing against each other and a second part able to be provided on the free side of the other of the two hollow biological tissues bearing against each other, the first part comprising two rows of needles enabling the walls of the two hollow biological tissues to be pierced to bring a first suturing thread, and optionally a cut for incising both walls, the second part comprising means for providing a second suturing thread in the loops of the first suturing thread. | 12-08-2011 |